Fonar Logo
diagnostic imaging management services

* FONAR is not responsible for the accuracy of information on these servers. This link is provided for your convenience only.

 

Fonar Financials Filed with the SEC

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

 

SEC Accession No. 0000355019-21-000009

Filing Date
2021-02-16
Accepted
2021-02-16 15:03:39
Documents
63
Period of Report
2020-12-31
 
Interactive Data
Document Format Files
Seq Description Document Type
1 FONAR CORPORATION 10-Q ENDED DECEMBER 31, 2020 fonar_10q-final.htm 10-Q
2 GRAPHIC fonar-logo.jpg GRAPHIC
3 CERTIFICATION fonar_exhibit-31.htm EX-31.1
4 CERTIFICATION fonar_exhibit-32.htm EX-32.1
  Complete submission text file 0000355019-21-000009.txt  

Data Files
Seq Description Document Type
5 XBRL PRESENTATION FILE fonr-20201231_pre.xml EX-101.PRE
6 XBRL LABEL FILE fonr-20201231_lab.xml EX-101.LAB
7 XBRL DEFINITION FILE fonr-20201231_def.xml EX-101.DEF
8 XBRL CALCULATION FILE fonr-20201231_cal.xml EX-101.CAL
9 XBRL SCHEMA FILE fonr-20201231.xsd EX-101.SCH
10 XBRL INSTANCE FILE fonr-20201231.xml EX-101.INS
       

FONAR CORPORATION (Filer) CIK: 0000355019

IRS No.: 112464137 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-10248 | Film No.: 21636746
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Office of Life Sciences

Business Address

110 Marcus Drive
Melville, NY 11740
631-694-2929
Mailing Address

110 Marcus Drive
Melville, NY 11740